Hi-Clearance

TWO:1788 Taiwan Medical Devices
Market Cap
$184.35 Million
NT$6.10 Billion TWD
Market Cap Rank
#18056 Global
#796 in Taiwan
Share Price
NT$137.00
Change (1 day)
-0.36%
52-Week Range
NT$135.50 - NT$144.50
All Time High
NT$149.30
About

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more

Hi-Clearance - Asset Resilience Ratio

Latest as of September 2025: 2.55%

Hi-Clearance (1788) has an Asset Resilience Ratio of 2.55% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
NT$127.12 Million
Cash + Short-term Investments
Total Assets
NT$4.99 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Hi-Clearance's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Hi-Clearance's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$127.12 Million 2.55%
Total Liquid Assets NT$127.12 Million 2.55%

Asset Resilience Insights

  • Limited Liquidity: Hi-Clearance maintains only 2.55% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hi-Clearance Industry Peers by Asset Resilience Ratio

Compare Hi-Clearance's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Hi-Clearance (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Hi-Clearance.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.63% NT$130.66 Million NT$4.96 Billion +0.23pp
2023-12-31 2.40% NT$110.86 Million NT$4.62 Billion +0.34pp
2022-12-31 2.06% NT$93.01 Million NT$4.51 Billion +0.72pp
2021-12-31 1.34% NT$59.55 Million NT$4.44 Billion -0.12pp
2020-12-31 1.47% NT$61.65 Million NT$4.20 Billion -0.55pp
2019-12-31 2.01% NT$75.07 Million NT$3.73 Billion -2.36pp
2018-12-31 4.38% NT$129.95 Million NT$2.97 Billion -1.10pp
2017-12-31 5.48% NT$143.14 Million NT$2.61 Billion -1.20pp
2016-12-31 6.68% NT$165.10 Million NT$2.47 Billion --
pp = percentage points